Skip to content

Bioventus BVS Deferred Taxes

Deferred Taxes at other companies

Artivion logo
ArtivionAORT
$27.64M+28.4%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$30M-0.2%
IAR
Integra LifeSciencesIART
$6.14M-89.3%
Avanos Medical logo
Avanos MedicalAVNS
$5.6M0.0%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$132.1M+6.6%
Gross profit$90.8M+9.3%
Operating income$8.4M+72.8%
Net income$3.1M+218%
EPS (diluted)$0.04+200%

Balance sheet

See full
Cash & equivalents$35.8M+57.2%
Total debt$288.4M-21.2%
Total equity$188.9M+27.5%
Total assets$650.5M-5.9%

Cash flow

See full
Operating cash flow$8.9M+146%
CapEx$574.0K-30.5%
Free cash flow$8.4M+141%

Valuation

See full
Market cap$659.19M+51.7%
Enterprise value$911.76M+17.2%
P/E23.1×
P/S1.1×+0.4×

Profitability

See full
Gross margin68.7%+1.2pp
Operating margin10%
Net margin4.9%+3.2pp
FCF margin17.5%+13.2pp

Returns & leverage

See full
Return on equity16.9%+10.9pp
Debt / equity1.5×-0.9×
Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bioventus's deferred taxes?
Bioventus (BVS) reported deferred taxes of $568K in Q1 2026.
How has Bioventus's deferred taxes changed year-over-year?
Bioventus's deferred taxes decreased by 6.4% year-over-year, from $607K to $568K.
What is the long-term trend for Bioventus's deferred taxes?
Over 5 years (2020 to 2025), Bioventus's deferred taxes has grown at a -33.6% compound annual growth rate (CAGR), from $3.36M to $433K.
What does deferred taxes mean?
This represents the net amount of income taxes that will be payable in future periods due to temporary differences between the carrying amount of assets and liabilities for financial reporting and their tax bases. It reflects the long-term tax impact of accounting choices and depreciation schedules. Investors use this to understand future tax obligations and the impact of tax timing on cash flow.